Novel Circulating Biomarker for Hepatocellular Carcinoma
Abstract
The major goal of the research study is to enumerate biologically distinct liver cancer CTCs and investigate the association between the specific subtype of CTCs and liver cancer grade, stage, and progression after treatment. Successful completion of the project will improve disease monitoring, prognosis prediction, and selection of treatment in the era of precision medicine for liver cancer.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2022
- Accession Number
- AD1190735
Entities
People
- Ju D. Yang
Organizations
- Cedars-Sinai Medical Center